Moderna CEO Stéphane Bancel at a meeting with President Donald Trump, members of the White House coronavirus task force, and pharmaceutical executives on March 2. Andrew Harnik/AP Images Moderna on Monday will file for emergency-use authorization of its experimental coronavirus vaccine, the company said. The biotech company said the vaccine was 94.1% effective against COVID-19 in an analysis of a late-stage trial. If the Food and Drug Administration authorizes the vaccine, the US intends to start vaccinating vulnerable people before the end of 2020. For more stories like this, sign up here for Business Insider's daily healthcare newsletter. Moderna is set to ask US regulators to allow the emergency use of its coronavirus vaccine, starting a process that could allow the shot to be given more widely within weeks.The biotech company plans to file for emergency-use authorization with the US Food and Drug Administration on Monday, Moderna said in a statement, about a week after Pfizer and BioNTech asked the FDA to authorize their vaccine.

BING NEWS:
  • Moderna says next generation COVID vaccine meets trial goal
    4/BA.5 variant and original strains of the coronavirus compared with Spikevax. Moderna has been working on multiple new messenger RNA vaccines, including the recently approved RSV vaccine ...
    06/13/2024 - 1:37 am | View Link
  • Two-in-one flu and Covid jab passes advanced trial
    Drug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a single shot, has passed a vital part of final-stage scientific checks. The phase-three trial shows ...
    06/9/2024 - 1:01 pm | View Link
  • Moderna's RSV Vaccine Approved by FDA
    The US Food and Drug Administration (FDA) approved mRESVIA (mRNA-1345, Moderna), a vaccine for respiratory syncytial virus (RSV). The mRNA vaccine is approved for adults aged 60 years or older to ...
    06/2/2024 - 1:00 pm | View Link
  • US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
    Moderna had filed for FDA approval in July on data from a late-stage trial that showed its vaccine was 84% effective at preventing those symptoms, and its shares were down more than 6% in ...
    05/31/2024 - 10:51 am | View Link
  • Moderna’s vaccine for RSV gets FDA approval for people 60 and older
    Like Moderna’s vaccine for COVID-19, which was authorized for emergency use by the FDA in December 2020 and ... vaccines that protect people from the coronavirus that caused a global pandemic.
    05/31/2024 - 8:14 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News